Literature DB >> 7329486

Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis.

J Rubin, R Ray, T Barnes, J Bower.   

Abstract

Exchanges were performed in 1-hour and 3- to 5-hour cycles when patients were noninfected and during episodes of peritonitis. The hourly exchange dialysate effluent volume decreased with the occurrence of peritonitis. These exchanges were associated with increased glucose absorption from dialysate, diminished sodium removal and augmented clearances of urea and creatinine. Protein losses were increased in the dialysate effluent of patients during an episode of peritonitis during the hourly exchanges. In the long-dwell exchanges obtained after clinical improvements of peritonitis, only protein losses were increased over control. Clearances, sodium loss in dialysate and glucose absorption were not altered from control.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7329486     DOI: 10.1159/000182328

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  R H Barbhaiya; C A Knupp; M Pfeffer; D Zaccardelli; G M Dukes; W Mattern; K A Pittman; L J Hak
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 2.  Peritoneal dialysis associated infections: An update on diagnosis and management.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-08-06

3.  Usefulness of light microscopic and Cytur test estimation of peritoneal dialysate in early diagnosis of peritonitis.

Authors:  W Sułowicz
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

4.  Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.

Authors:  T A Golper; A I Hartstein; V H Morthland; J M Christensen
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

5.  Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis.

Authors:  Sashikala Kopanati; Michel Baum; Albert Quan
Journal:  Pediatr Nephrol       Date:  2006-05-20       Impact factor: 3.714

6.  Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.

Authors:  C A Johnson; S W Zimmerman; D P Reitberg; T J Whall; J E Leggett; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

7.  Factors affecting Staphylococcus epidermidis growth in peritoneal dialysis solutions.

Authors:  W A McDonald; J Watts; M I Bowmer
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.